• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[采用周期性乳房疼痛治疗乳腺病。临床结果与激素谱分析]

[Treatment of mastopathies with cyclic mastodynia. Clinical results and hormonal profiles].

作者信息

Kubista E, Müller G, Spona J

出版信息

Rev Fr Gynecol Obstet. 1987 Apr;82(4):221-7.

PMID:3589362
Abstract

The therapeutic effect of a long-term Gestagen therapy (lynestrenol) and a phytotherapy (Mastodynon) in comparison to a placebo group is reported in 160 cases of severe mastopathy with cyclic mastalgia. In 82.1 percent of the patients in the gestagen-group and in 74.5 percent of the patients in the Mastodynon-group a good relief of the premenstrual symptoms was achieved. In the placebo group only 36.8 percent of the patients reported a relief of symptoms. The difference is significant. The evaluation and analysis of serum HPRL and serum-progesterone showed a significant rise of the HPRL-level and a significant decrease of the progesterone-level. Because of this severe influence on the endocrine balance the recommendation for an alternative phytotherapy prior to a long term gestagen therapy is justified.

摘要

报告了长期使用孕激素疗法(炔诺酮)和植物疗法(Mastodynon)与安慰剂组相比,对160例伴有周期性乳腺疼痛的严重乳腺病患者的治疗效果。在孕激素组中82.1%的患者以及Mastodynon组中74.5%的患者经前症状得到了很好的缓解。在安慰剂组中只有36.8%的患者报告症状有所缓解。差异具有显著性。血清泌乳素(HPRL)和血清孕酮的评估与分析显示,HPRL水平显著升高,孕酮水平显著降低。鉴于对内分泌平衡的这种严重影响,在长期孕激素治疗之前推荐采用替代性植物疗法是合理的。

相似文献

1
[Treatment of mastopathies with cyclic mastodynia. Clinical results and hormonal profiles].[采用周期性乳房疼痛治疗乳腺病。临床结果与激素谱分析]
Rev Fr Gynecol Obstet. 1987 Apr;82(4):221-7.
2
[Treatment of mastopathy with cyclic mastodynia: clinical results and hormone profile].[采用周期性乳房疼痛治疗乳腺病:临床结果与激素水平]
Gynakol Rundsch. 1986;26(2):65-79.
3
[Conservative therapy of mastopathy].
Zentralbl Gynakol. 1983;105(18):1153-62.
4
Relationship of mastodynia with its endocrine environment and treatment in a double blind trial with lynestrenol.在一项炔雌醇双盲试验中乳腺疼痛与其内分泌环境及治疗的关系
Arch Gynakol. 1978 Feb 22;225(1):7-13. doi: 10.1007/BF00672829.
5
[Enzyme therapy in treatment of mastopathy. A randomized double-blind clinical study].[酶疗法治疗乳腺病。一项随机双盲临床研究]
Wien Klin Wochenschr. 1996;108(6):180-3.
6
[Treatment of mastopathy: the last possible risk].[乳腺病的治疗:最后的潜在风险]
Med Klin. 1981 Sep 25;76(20):566-7.
7
[Treatment of mastodynia and mastopathy using Mastodynon].使用消乳胀痛片治疗乳腺疼痛和乳腺病
Med Welt. 1976 Mar 19;27(12):591-2.
8
[Aetiology, diagnosis und therapy of mastopathy and mastodynia. Experiences of treatment with mastodynon (author's transl)].[乳腺病和乳腺疼痛的病因、诊断及治疗。使用消乳胀痛(作者译)治疗的经验]
Med Klin. 1977 Aug 26;72(34):1327-30.
9
A double-blind randomized controlled trial of toremifen therapy for mastalgia.托瑞米芬治疗乳腺疼痛的双盲随机对照试验。
Arch Surg. 2006 Jan;141(1):43-7. doi: 10.1001/archsurg.141.1.43.
10
Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis.比较醋酸戈舍瑞林激动剂和炔诺酮治疗重度子宫内膜异位症的前瞻性随机研究。
Gynecol Endocrinol. 2001 Jun;15(3):202-9.

引用本文的文献

1
TIM3 comes of age as an inhibitory receptor.TIM3 作为抑制性受体崭露头角。
Nat Rev Immunol. 2020 Mar;20(3):173-185. doi: 10.1038/s41577-019-0224-6. Epub 2019 Nov 1.